These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 22954960)
21. Alcohol consumption and risk of ischemic heart disease in women. Garg R; Wagener DK; Madans JH Arch Intern Med; 1993 May; 153(10):1211-6. PubMed ID: 8494473 [TBL] [Abstract][Full Text] [Related]
22. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Ioannou GN; Boyko EJ; Lee SP Am J Gastroenterol; 2006 Jan; 101(1):76-82. PubMed ID: 16405537 [TBL] [Abstract][Full Text] [Related]
23. Regional variations in cardiovascular mortality in Canada. Filate WA; Johansen HL; Kennedy CC; Tu JV Can J Cardiol; 2003 Oct; 19(11):1241-8. PubMed ID: 14571309 [TBL] [Abstract][Full Text] [Related]
24. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality. Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024 [TBL] [Abstract][Full Text] [Related]
26. Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans. Yun KE; Shin CY; Yoon YS; Park HS Atherosclerosis; 2009 Aug; 205(2):533-7. PubMed ID: 19159884 [TBL] [Abstract][Full Text] [Related]
27. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study. Lemaitre RN; King IB; Mozaffarian D; Sotoodehnia N; Rea TD; Kuller LH; Tracy RP; Siscovick DS Circulation; 2006 Jul; 114(3):209-15. PubMed ID: 16818809 [TBL] [Abstract][Full Text] [Related]
28. Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population. Olynyk JK; Knuiman MW; Divitini ML; Davis TM; Beilby J; Hung J Am J Gastroenterol; 2009 Jul; 104(7):1715-22. PubMed ID: 19491832 [TBL] [Abstract][Full Text] [Related]
29. Fatigue, general health, and ischemic heart disease in older adults. Ekmann A; Petersen I; Mänty M; Christensen K; Avlund K J Gerontol A Biol Sci Med Sci; 2013 Mar; 68(3):279-85. PubMed ID: 22967457 [TBL] [Abstract][Full Text] [Related]
30. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis. Fernández-Reyes MJ; Mon C; Heras M; Guevara P; Garcia MC; Sanchez R; Velasco S; Alvarez-Ude F J Nephrol; 2004; 17(5):721-7. PubMed ID: 15593041 [TBL] [Abstract][Full Text] [Related]
31. Past and current alcohol consumption patterns and elevations in serum hepatic enzymes among US adults. Tsai J; Ford ES; Li C; Zhao G Addict Behav; 2012 Jan; 37(1):78-84. PubMed ID: 21975024 [TBL] [Abstract][Full Text] [Related]
32. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067 [TBL] [Abstract][Full Text] [Related]
33. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Stepanova M; Rafiq N; Younossi ZM Gut; 2010 Oct; 59(10):1410-5. PubMed ID: 20660697 [TBL] [Abstract][Full Text] [Related]
34. The predictive value of fatigue for nonfatal ischemic heart disease and all-cause mortality. Ekmann A; Osler M; Avlund K Psychosom Med; 2012 Jun; 74(5):464-70. PubMed ID: 22685239 [TBL] [Abstract][Full Text] [Related]
35. Sex disparities in risk and risk factors for ischemic heart disease in the Asia-Pacific region. Peters SA; Woodward M; Lam TH; Fang X; Suh I; Ueshema H; Dobson AJ; Grobbee DE; Huxley RR; Eur J Prev Cardiol; 2014 May; 21(5):639-46. PubMed ID: 23536283 [TBL] [Abstract][Full Text] [Related]
36. Behavioral risk factors and socioeconomic inequalities in ischemic heart disease mortality in the United States: A causal mediation analysis using record linkage data. Zhu Y; Llamosas-Falcón L; Kerr WC; Rehm J; Probst C PLoS Med; 2024 Sep; 21(9):e1004455. PubMed ID: 39288102 [TBL] [Abstract][Full Text] [Related]
37. Associations between selected laboratory tests and all-cause mortality. Hu G; Duncan AW J Insur Med; 2013; 43(4):208-20. PubMed ID: 24069781 [TBL] [Abstract][Full Text] [Related]
38. Mendelian randomization estimates of alanine aminotransferase with cardiovascular disease: Guangzhou Biobank Cohort study. Xu L; Jiang CQ; Lam TH; Zhang WS; Zhu F; Jin YL; Thomas GN; Cheng KK; Schooling CM Hum Mol Genet; 2017 Jan; 26(2):430-437. PubMed ID: 28007909 [TBL] [Abstract][Full Text] [Related]
39. Mortality from ischaemic heart disease: sex-specific effects of transferrin saturation, serum iron, and total iron binding capacity. The HUNT study. Mørkedal B; Laugsand LE; Romundstad PR; Vatten LJ Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):687-94. PubMed ID: 21450624 [TBL] [Abstract][Full Text] [Related]
40. Impact of diabetes on heart failure incidence in adults with ischemic heart disease. Patel N; Chen O; Donahue C; Wang B; Fang Y; Donnino R; Natarajan S J Diabetes Complications; 2017 Nov; 31(11):1597-1601. PubMed ID: 28947278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]